Dermatology · Boca Raton, FL
NPI
1265449003
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
4601 N Federal Hwy
Boca Raton, FL, 33431
Phone (561) 362-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
15,498 services
Medicare patients, 2024
1,725
Average age 78
Drug cost, 2024
$490K
2,058 prescriptions
Company payments, 2025
$89K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Fromowitz was code 17003 (destruction skin lesion), 3,615 times for 629 patients. In total Jeffrey S Fromowitz billed 15,498 services in 79 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,615 | 629 | $4.82 | $17K |
| 99214 Office E&M - Established | Office | 1,999 | 1,216 | $98.69 | $197K |
| 17110 Destruction Skin Lesion | Office | 1,876 | 1,074 | $81.56 | $153K |
| 17000 Destruction Skin Lesion | Office | 1,272 | 882 | $32.59 | $41K |
| 99213 Office E&M - Established | Office | 1,188 | 708 | $69.66 | $83K |
| 11102 Skin Biopsy | Office | 1,176 | 828 | $47.42 | $56K |
| 17004 Destruction Skin Lesion | Office | 1,080 | 610 | $124.37 | $134K |
| 11103 Skin Biopsy | Office | 489 | 298 | $38.90 | $19K |
| 99212 Office E&M - Established | Office | 443 | 251 | $43.17 | $19K |
| 17311 Mohs Surgery | Office | 319 | 237 | $534.33 | $170K |
| 99203 Office E&M - New | Office | 204 | 204 | $81.68 | $17K |
| 17313 Mohs Surgery | Office | 203 | 147 | $496.90 | $101K |
| 77401 Conventional Radiation Treatment | Office | 181 | 16 | $32.25 | $5,838 |
| 10040 Removal or Shaving of Skin Growth | Office | 161 | 143 | $83.28 | $13K |
| 96910 Skin | Office | 156 | 17 | $89.39 | $14K |
By year: 2022 $1.2M for 18,706 services; 2023 $1.2M for 16,967 services; 2024 $1.2M for 15,498 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Fromowitz prescribed most often to Medicare patients was Triamcinolone Acetonide, with 291 prescriptions and refills. In total Jeffrey S Fromowitz wrote 2,058 Medicare prescriptions that cost $490K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 291 | 342 | 217 | $4,441 |
| Mupirocin Generic | 268 | 268 | 205 | $2,084 |
| Doxycycline Hyclate Generic | 227 | 271 | 164 | $2,830 |
| Hydrocortisone Generic | 192 | 216 | 152 | $1,508 |
| Ketoconazole Generic | 180 | 202 | 108 | $3,362 |
| Clobetasol Propionate Generic | 148 | 157 | 103 | $6,030 |
| Minoxidil Generic | 93 | 189 | 31 | $873 |
| Ciclopirox Generic | 75 | 79 | 50 | $3,057 |
| Terbinafine Hcl Generic | 58 | 59 | 41 | $231 |
| Cephalexin Generic | 54 | 54 | 48 | $368 |
| Fluorouracil Generic | 47 | 47 | 40 | $2,536 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 45 | 48 | 24 | $979 |
| Valacyclovir Valacyclovir Hcl | 42 | 49 | 31 | $1,269 |
| Metronidazole Generic | 24 | 27 | 19 | $1,086 |
| Dupixent Pen Dupilumab | 22 | 26 | Under 11 | $101K |
Brand drugs: 92 claims; generic drugs: 1,966 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Fromowitz $89K ($89K in general payments such as food, travel and fees) from 23 companies. The largest payer was Galderma Laboratories, L.P. with $23K.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 45 | $23K |
| Regeneron Healthcare Solutions, Inc. REGN | 13 | $16K |
| Incyte Corporation INCY | 32 | $15K |
| Amgen Inc. AMGN | 25 | $13K |
| Pfizer Inc. PFE | 6 | $9,290 |
| Botanix SB Inc | 14 | $5,745 |
| Genzyme Corporation SNY | 13 | $5,195 |
| Abbvie Inc. ABBV | 15 | $275 |
| Arcutis Biotherapeutics, Inc. ARQT | 25 | $193 |
| LEO Pharma Inc. | 14 | $184 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.